3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying

Zacks Dec 24 20:00

Vanda Pharma Analyst Ratings

BenzingaDec 23 19:50 · Ratings

Vanda Pharmaceuticals: Promising Pipeline Developments and Market Potential Drive Buy Rating

TipRanksDec 23 19:25 · Ratings

Vanda Pharmaceuticals Gets FDA Orphan-Drug Designation for Cancer Treatment

WSJDec 20 22:37

Express News | Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for Vgt-1849a, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

BreakingsDec 20 22:13

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

BusinesswireDec 17 10:29